节点文献

托吡司他的合成工艺研究

Study on synthetic process of topiroxostat

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 葛宫慧郭帅张旭张廷剑孟繁浩

【Author】 GE Gonghui;GUO Shuai;ZHANG Xu;ZHANG Tingjian;MENG Fanhao;School of Pharmacy,China Medical University;

【通讯作者】 张廷剑;孟繁浩;

【机构】 中国医科大学药学院

【摘要】 目的 优化托吡司他的合成工艺。方法 以2-氯异烟酸(2)为起始原料,经氯代、醇解、肼解反应得到2-氯异烟肼(5);以4-氰基吡啶(6)为起始原料,在甲醇钠催化下与甲醇反应生成异烟亚氨酸甲酯(7);化合物5和7经环合、氰基化反应制得托吡司他。结果与结论目标产物结构经1H-NMR,13C-NMR和ESI-MS谱确证,总收率为52.3%(以2-氯异烟酸计),纯度为99.95%(HPLC法)。该合成方法原料价廉易得、成本低、操作简便、选择性好、工艺稳定,有利于工业化生产。

【Abstract】 Topiroxostat is a xanthine oxidase inhibitor widely used in the treatment of gout and hyperuricemia,demonstrating significant clinical efficacy and good tolerability.In this study,we developed a new synthetic route inspired by previous literature methods.With2-chloroisonicotinic acid(2)as the raw material,2-chloroisonicotinohydrazide(5)was synthesized through chlorination,alcoholysis and hydrazinolysis reactions.Meanwhile,4-cyanopyridine(6)was used as the starting material and reacted with methanol under sodium methoxide catalysis to produce methyl isonicotinimidate(7).Compounds 5 and 7were then subjected to cyclization and cyanation reactions to give topiroxostat(1)with an overall of52.3%(based on2-chloroisonicotinic acid)and a purity of99.95%(HPLC).The structure of the target produc was confirmed by 1H-NMR,13 C-NMR and ESI-MS.This synthesis method offers advantages such as readily available raw materials,lower cost,simpler operation,higher selectivity and stable processes,and is suitable for industrial production.■

【关键词】 托吡司他合成工艺痛风
【Key words】 topiroxostatsynthetic processgout
【基金】 国家自然科学基金项目(82273785)
  • 【文献出处】 中国药物化学杂志 ,Chinese Journal of Medicinal Chemistry , 编辑部邮箱 ,2024年06期
  • 【分类号】R914
  • 【下载频次】21
节点文献中: 

本文链接的文献网络图示:

本文的引文网络